In The Rear View Mirror: April continues to be a tricky month, and that’s putting it delicately for U.S. stocks. Sure, the Dow Jones Industrial
Read More
High growth potential and the chances for extraordinary profits in short order are just two of the main reasons investors continue to love biotech micro-caps.
Read More In The Rear View Mirror: Maybe April showers will bring some May flowers, but the storm U.S. stocks have drummed up in 2012 has been
Read MoreThere are myriad ways for investors to get exposure to the energy sector, but too often that means playing the same old boring big cap
Read MoreChances are that if you’re not invested in one, you’ve at least heard about master limited partnerships (MLPs), even the micro-cap variety, over the past few
Read MoreFollowing a wild 2011 at the hands of a slack global economy and China’s dubious export policies, the rare earths sector is undergoing a renaissance
Read More In The Rear View Mirror: It took just four trading days for the S&P 500 to slide 0.7% and notch its worst weekly performance of
Read More In The Rear View Mirror: U.S. stocks were able to close the first quarter on a high note as the S&P 500 and Dow Jones
Read More
Every stock investor likes dividends, but not everyone associates the microcap universe as home to dependable dividend payers with juicy yields. That’s understandable because so
Read More
By now, most investors have at least heard of the Bakken Shale, a massive formation that reaches from Canada down to North Dakota and Montana.
Read More
